As shown in Fig. 1b, SPRY4-IT1 was present at higher levels in CCA cells (CCLP-1, HCCC-9810, HuCCT1, Huh-28 and RBE) compared with HIBEC. This evidence concerns the gene SPRY4 and cholangiocarcinoma.